Ronald W Rudolph - Net Worth and Insider Trading
Ronald W Rudolph Net Worth
The estimated net worth of Ronald W Rudolph is at least $2 Million dollars as of 2024-05-26. Ronald W Rudolph is the Executive VP, Finance & CFO of ASGN Inc and owns about 18,086 shares of ASGN Inc (ASGN) stock worth over $2 Million. Details can be seen in Ronald W Rudolph's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Ronald W Rudolph has not made any transactions after 2004-03-15 and currently still holds the listed stock(s).
Transaction Summary of Ronald W Rudolph
Ronald W Rudolph Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Ronald W Rudolph owns 2 companies in total, including Targeted Medical Pharma Inc (TRGM) , and ASGN Inc (ASGN) .
Click here to see the complete history of Ronald W Rudolph’s form 4 insider trades.
Insider Ownership Summary of Ronald W Rudolph
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TRGM | Targeted Medical Pharma Inc | 2012-06-22 | See Remarks |
| ASGN | ASGN Inc | 2004-03-15 | Executive VP & Finance & CFO |
Ronald W Rudolph Latest Holdings Summary
Ronald W Rudolph currently owns a total of 1 stock. Ronald W Rudolph owns 18,086 shares of ASGN Inc (ASGN) as of March 15, 2004, with a value of $2 Million.
Ronald W Rudolph Form 4 Trading Tracker
According to the SEC Form 4 filings, Ronald W Rudolph has made a total of 0 transactions in ASGN Inc (ASGN) over the past 5 years. The most-recent trade in ASGN Inc is the acquisition of 5,000 shares on March 15, 2004, which cost Ronald W Rudolph around $28,750.
Insider Trading History of Ronald W Rudolph
- 1
Ronald W Rudolph Trading Performance
GuruFocus tracks the stock performance after each of Ronald W Rudolph's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Ronald W Rudolph is -2.54%. GuruFocus also compares Ronald W Rudolph's trading performance to market benchmark return within the same time period. The performance of stocks bought by Ronald W Rudolph within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Ronald W Rudolph's insider trading performs compared to the benchmark.
Performance of Ronald W Rudolph
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 9.98 | | | | | |
| Relative Return to S&P 500(%) | 7.78 | | | | | |
Ronald W Rudolph Ownership Network
Ronald W Rudolph Owned Company Details
What does Targeted Medical Pharma Inc do?
Who are the key executives at Targeted Medical Pharma Inc?
Ronald W Rudolph is the See Remarks of Targeted Medical Pharma Inc. Other key executives at Targeted Medical Pharma Inc include Chief Financial Officer William B. Horne , director & 10 percent owner & Former President Amir F Heshmatpour , and Chief Financial Officer Steve B Warnecke .
Targeted Medical Pharma Inc (TRGM) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Targeted Medical Pharma Inc (TRGM) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Targeted Medical Pharma Inc (TRGM) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Targeted Medical Pharma Inc (TRGM)'s detailed insider trading history can be found in Insider Trading Tracker table.
Targeted Medical Pharma Inc Insider Transactions
Ronald W Rudolph Mailing Address
Above is the net worth, insider trading, and ownership report for Ronald W Rudolph. You might contact Ronald W Rudolph via mailing address: C/o Targeted Medical Pharma, Inc, 2980, Beverly Glen Circle, Suite 301, Los Angeles Ca 90077.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
